New Hanover Regional Medical Center Radiation Oncology has successfully met the standards of the American Society for Radiation Oncology (ASTRO) Accreditation Program for Excellence (APEx). The APEx accreditation program validates a radiation oncology facility’s excellence in delivering high-quality patient care. The four-year accreditation is effective through 2023.
“We are pleased to receive this accreditation,” said Michelle Hoadley, Director of Radiation Oncology. “Our entire radiation oncology team was invested in evaluating our processes to meet the high standards for safety and quality. Securing APEx accreditation serves to reinforce our obligation to deliver consistent patient-centered cancer care.”
Accreditation through APEx is a voluntary and rigorous multi-step process during which a facility’s practices are evaluated using consensus-based standards. The center must demonstrate its safety and quality processes and demonstrate that it adheres to patient-centered care by promoting effective communication, coordinated treatments and strong patient engagement.
The APEx accreditation process includes a facility self-assessment as well as a comprehensive onsite facility review by a radiation oncologist and a medical physicist. NHRMC is among fewer than 200 facilities across the U.S. that have received APEx accreditation.
For more information about NHRMC Radiation Oncology, visit www.nhrmc.org/cancer.